Nurix Therapeutics Inc (NRIX) — Financial Flexibility Index
Nurix Therapeutics Inc (NRIX) has a Financial Flexibility Index of -0.36x as of August 2025. Free cash flow of $-54.67 Million (operating CF $-57.38 Million minus capex $2.71 Million) represents 0% of total liabilities ($150.22 Million). Check Nurix Therapeutics Inc (NRIX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nurix Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Nurix Therapeutics Inc across 7 annual periods. See Nurix Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Nurix Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Nurix Therapeutics Inc. For the full company profile including market capitalisation, see Nurix Therapeutics Inc (NRIX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.15x | $-163.31 Million | $-172.58 Million | $142.35 Million | ▼ -143.9% |
| 2023 | -0.47x | $-72.96 Million | $-81.36 Million | $155.10 Million | ▲ +64.0% |
| 2022 | -1.31x | $-147.56 Million | $-159.81 Million | $113.06 Million | ▼ -123.0% |
| 2021 | -0.59x | $-78.70 Million | $-84.36 Million | $134.47 Million | ▼ -1488.0% |
| 2020 | 0.04x | $4.47 Million | $-80.00K | $106.07 Million | ▲ +0.3% |
| 2019 | 0.04x | $2.25 Million | $601.00K | $53.57 Million | ▲ +104.8% |
| 2018 | -0.88x | $-30.08 Million | $-31.68 Million | $34.05 Million | — |